Norgine Pharmaceuticals
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Norgine House Widewater Place Moorhall R...Phone Number
+44 1895826606Website
www.targaxan.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Norgine Pharmaceuticals
Norgine Pharmaceuticals Limited specializes in the licensed treatment TARGAXAN (rifaximin-alpha), aimed at reducing the recurrence of overt hepatic encephalopathy (OHE). The company primarily serves healthcare professionals in the UK, providing them with essential information about the product. TARGAXAN is a registered trademark licensed from Alfasigma S.p.A. and is part of Norgine's portfolio of pharmaceutical products.Explore more
Popular SearchesNorgine Pharmaceuticals LtdSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Norgine Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Norgine Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Norgine Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Norgine Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Norgine Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Norgine Pharmaceuticals
Check out if Norgine Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Norgine Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Norgine Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Norgine Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Norgine Pharmaceuticals
Compare insights from companies similar to Norgine Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Norgine Pharmaceuticals
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Norgine Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Norgine Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Norgine Pharmaceuticals.
Norgine Pharmaceuticals Tech Stack
A closer look at the technologies used by Norgine Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Norgine Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Norgine Pharmaceuticals Limited specializes in the licensed treatment TARGAXAN (rifaximin-alpha), aimed at reducing the recurrence of overt hepatic encephalopathy (OHE). The company primarily serves healthcare professionals in the UK, providing them with essential information about the product. TARGAXAN is a registered trademark licensed from Alfas... Read More
